Combining Daratumumab with VRd Improves Outcomes in Patients with Transplant-Ineligible or Transplant-Deferred Newly Diagnosed Multiple Myeloma By Ogkologos - March 3, 2025 633 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the CEPHEUS study Source RELATED ARTICLESMORE FROM AUTHOR FX-909 Demonstrates Acceptable Safety and Preliminary Antitumour Activity, Establishing a Proof of Concept for PPARγ Inverse Agonism in Advanced Urothelial Cancer Pimicotinib Shows Robust Antitumour Activity and Clinically Meaningful Improvements in Patients with Tenosynovial Giant Cell Tumour FDA Grants Accelerated Approval to Zongertinib for Unresectable or Metastatic Non-Squamous NSCLC MOST POPULAR Mom Walks In To Comfort Scared Son After Surgery And Sees... June 26, 2019 Apple Season is Here! October 1, 2021 Camonsertib in Patients with Advanced Solid Tumours Harbouring Loss of Function... July 3, 2023 ESMO Issues First Recommendations on Using Next-Generation Sequencing for Advanced Cancers... August 24, 2020 Load more HOT NEWS PD1 and LAG3 Inhibition Plus Chemoradiotherapy in the Neoadjuvant Setting for... Dr. Catherine Hamlin, Pioneer In Fistula Surgery, Passes Away At Age... How I Navigated the Challenges of 2 Colorectal Cancer Diagnoses As... Reducing Health Care Disparities Through Cancer Clinical Trials
